Lilly will supply up to 600,000 doses of bebtelovimab to U.S. government in ongoing effort to provide COVID-19 treatment optionsPRNewsWire • 02/10/22
Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly's Pipeline ProgramsBusiness Wire • 02/09/22
Eli Lilly brings in over $1.0 billion in quarterly COVID-19 antibody salesThe Dog of Wall Street • 02/03/22
Eli Lilly and Company (LLY) CEO David Ricks on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/03/22
Cramer's Investing Club: Buy Eli Lilly's drop on drug delay news because it won't matter long termCNBC • 02/03/22
Eli Lilly Q4 Earnings Beat Estimates On Higher Demand For Trulicity, COVID-19 Therapies; Reaffirms FY22 GuidanceBenzinga • 02/03/22
Eli Lilly stock gains after earnings rise above expectations, as COVID-19 antibodies revenue top $1 billionMarket Watch • 02/03/22
Lilly Reports Solid Fourth-Quarter and Full-Year 2021 Financial Results, Recent Late-Stage Pipeline Successes Set Up Next Wave of Innovative Medicines for PatientsPRNewsWire • 02/03/22
UNICEF and Lilly Collaborate to Help Improve Health Outcomes for 10 Million Children and AdolescentsPRNewsWire • 02/02/22
Cramer's Investing Club Profile: Eli Lilly has one of best pipelines in the drug industryCNBC • 01/31/22
Lilly (LLY) Stops Lupus Study, Expects CRL for Olumiant in EczemaZacks Investment Research • 01/31/22
Lilly announces $1 billion investment in new manufacturing facility in North CarolinaPRNewsWire • 01/28/22